Scientific Advisory Board

The key functions of the CRF’s Scientific Advisory Board are:

  • advise on the overall scientific remit and direction of the CRF and, in doing so, inform high quality clinical research for the benefit of society in general
  • ensure that the CRF remains appraised of both leading-edge clinical research and external risks that may threaten the clinical research landscape by facilitating ‘horizon scanning’ activities

The current membership of the Scientific Advisory Board (SAB) is:

An Independent Chair – Professor Paul Brown: Consultant Haematologist SJH, Fellow Emeritus TCD

SAB Members:

Prof Louise Bowman: Professor of Medicine and Clinical Trials Oxford University
Dr Darrin Morrissey:  Chief Executive Officer at the National Institute for Bioprocessing Research and Training (NIBRT)
Dr Avril Kennan: CEO of Health Research Charities Ireland
Dr David Morrow: Scientific Lead for Advanced Therapies at the European Infrastructure for Translational Medicine (EATRIS)
Dr Caitriona Duggan: Country Director Amgen Ireland
Prof Alan Irvine: Consultant Dermatologist SJH, Professor of Dermatology TCD
Prof Orla Hardiman: Consultant Neurologist Beaumont Hospital, Professor of Neurology TCD
Prof Laurence Egan: Consultant Clinical Pharmacologist and Gastroenterologist, University Hospital Galway and University of Galway

Prof Jane Farrar: Professor of Ocular Genetics TCD

Prof. Athanasios (Sakis) Mantalaris: Don Panoz Chair of Pharmaceutical Biology, TCD

Prof Richard Reilly: Research Chair of Neural Engineering TCD

Dr Roisin Flynn: Senior Director, ExploR&D, Eli Lilly